As pharmacy compounders, what you don’t know can hurt you一and the patients you serve. It’s...
Webinar: Fighting misinfo with quality
APC has a timely, important webinar coming up on April 10 — “Debunking Myths About Sterile Compounded Hormones” featuring Ross Caputo, president and CEO of Eagle Analytical. Despite the title, it’s in fact a practical program, exploring how compounders can adopt testing practices similar to those used in big pharma to ensure the quality of their products. We’re talking the kind of rigorous sterility, potency, and endotoxin testing that align with the high standards of pharmaceutical manufacturing.
Why is this important now? Because as part of their disinformation campaigns, drugmakers are claiming that the API compounders use is somehow subpar to their own in an effort to get the FDA to ban semaglutide and tirzepatide compounding. That makes it the perfect time to learn about the advanced testing technologies, validation processes, and quality systems you can leverage to produce consistent, high-quality products.